Is NSC 299972 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use NSC 299972? Is NSC 299972 safe for nursing mother and child? Does NSC 299972 extracts into breast milk? Does NSC 299972 has any long term or short term side effects on infants? Can NSC 299972 influence milk supply or can NSC 299972 decrease milk supply in lactating mothers?

Antiprotozoan drug used for the treatment of American Trypanosomiasis (Trypanosoma cruzi) or Chagas Disease (see specific info). It is excreted into breast milk in small amounts and there have not been observed problems in infants from treated mothers (Garcia-Bournissen 2015, Vela-Bahena 2015). NSC 299972 has been very well tolerated when administered directly to infants and newborns (Altcheh 2011, Chippaux 2013).

NSC 299972 is excreted into milk in dosages much lower than the treatment dosage for infants. Because of the low levels of NSC 299972 in breastmilk and safety when given directly to infants, its use is acceptable in nursing mothers.

Ten women with chronic Chagas disease received NSC 299972 in a median oral dose of 5.65 mg/kg twice daily for 30 days. Median infant age Ten women with chronic Chagas disease received NSC 299972 in a median oral dose of 5.65 mg/kg twice daily for 30 days. Median infant age was 5.2 months (range 20 days-13 months). Five children were exclusively breastfed and the others partially breastfed. None of the infants had any adverse reactions attributable to NSC 299972.[4] A postpartum woman diagnosed with Chagas disease was treated with NSC 299972 5 mg/kg daily beginning one month postpartum and continuing for 30 days. She continued to breastfeed (extent not stated) her infant. The authors reported that no adverse effects were seen in the infant.[6]